Tohoku ChemicalTOHOKU CHEMICAL CO., LTD.7446東証スタンダード卸売業FY ending Sep 2025, consolidated, J-GAAP
Revenue by business segment, and the profit each one keeps.
Geographic revenue reported in annual filings
No geographic revenue breakdown was disclosed.
※ Segments without disclosed profit are drawn entirely as costs
※ Segment figures include inter-segment sales and do not sum to the company total
Each segment's revenue CAGR.
Industry sales group
Revenue ¥17.9B
+0.9%2 yr
Medical sales group
Revenue ¥14.1B
-4.1%2 yr
Academia, Life science sales group
Revenue ¥2.44B
+5.7%2 yr
Bars show each segment's revenue CAGR: growth to the right of zero, decline to the left. Colours only tell segments apart. This company does not disclose segment operating income, so a growth-versus-margin chart cannot be drawn.
| Segment | Revenue CAGR | FY ending Sep 2021 | FY ending Sep 2022 | FY ending Sep 2023 | FY ending Sep 2024 | FY ending Sep 2025 |
|---|---|---|---|---|---|---|
| Pharmaceutical products | — | 17,818 | 18,006 | 17,172 | — | — |
| Reagent for clinical test | — | 14,671 | 15,638 | 14,205 | — | — |
| Food | — | 3,315 | 3,307 | 3,348 | — | — |
| Industry sales group | +0.9%2y | — | — | 17,525 | 16,099 | 17,859 |
| Medical sales group | -4.1%2y | — | — | 15,387 | 14,125 | 14,144 |
| Academia, Life science sales group | +5.7%2y | — | — | 2,183 | 1,932 | 2,439 |
Top: revenue. Bottom: operating margin.
EDINET (FSA Japan)
有価証券報告書－第74期(2024/10/01－2025/09/30)
EDINET (FSA Japan)
有価証券報告書－第73期(2023/10/01－2024/09/30)
EDINET (FSA Japan)
有価証券報告書－第72期(2022/10/01－2023/09/30)
EDINET (FSA Japan)
訂正有価証券報告書－第71期(2021/10/01－2022/09/30)
EDINET (FSA Japan)
有価証券報告書
EDINET (FSA Japan)
有価証券報告書－第69期(令和1年10月1日－令和2年9月30日)
Extracted from XBRL: 52 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.